NL7909054A - Nieuwe verbindingen met formule 1, werkwijze voor de bereiding daarvan; farmaceutische preparaten. - Google Patents

Nieuwe verbindingen met formule 1, werkwijze voor de bereiding daarvan; farmaceutische preparaten. Download PDF

Info

Publication number
NL7909054A
NL7909054A NL7909054A NL7909054A NL7909054A NL 7909054 A NL7909054 A NL 7909054A NL 7909054 A NL7909054 A NL 7909054A NL 7909054 A NL7909054 A NL 7909054A NL 7909054 A NL7909054 A NL 7909054A
Authority
NL
Netherlands
Prior art keywords
formula
compound
acceptable salt
pharmaceutically acceptable
lower alkyl
Prior art date
Application number
NL7909054A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL7909054A publication Critical patent/NL7909054A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL7909054A 1978-12-18 1979-12-14 Nieuwe verbindingen met formule 1, werkwijze voor de bereiding daarvan; farmaceutische preparaten. NL7909054A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/970,517 US4200578A (en) 1978-12-18 1978-12-18 Thiazole derivatives
US97051778 1978-12-18

Publications (1)

Publication Number Publication Date
NL7909054A true NL7909054A (nl) 1980-06-20

Family

ID=25517073

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7909054A NL7909054A (nl) 1978-12-18 1979-12-14 Nieuwe verbindingen met formule 1, werkwijze voor de bereiding daarvan; farmaceutische preparaten.

Country Status (24)

Country Link
US (1) US4200578A (el)
JP (1) JPS5583768A (el)
KR (3) KR830001920B1 (el)
AT (1) AT375354B (el)
AU (1) AU533014B2 (el)
BE (1) BE880662A (el)
CA (1) CA1133909A (el)
CH (1) CH642956A5 (el)
DE (1) DE2950838A1 (el)
DK (1) DK533979A (el)
ES (2) ES487035A0 (el)
FI (1) FI793904A (el)
FR (1) FR2444674B1 (el)
GB (1) GB2038822B (el)
GR (1) GR73586B (el)
HU (1) HU182461B (el)
IE (1) IE49320B1 (el)
IL (1) IL58960A (el)
IT (1) IT1164076B (el)
LU (1) LU82000A1 (el)
NL (1) NL7909054A (el)
SE (1) SE444680B (el)
YU (3) YU292179A (el)
ZA (1) ZA796814B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
GR71929B (el) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
IE56763B1 (en) * 1983-02-07 1991-12-04 Lilly Co Eli Improvements in or relating to the synthesis of nizatidine
ZA869438B (en) * 1985-12-18 1988-07-27 Lilly Co Eli Synthesis of nizatidine
JPH0247453U (el) * 1988-09-29 1990-03-30
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer
CN111974333B (zh) * 2020-08-19 2023-06-09 宁夏亚东化工有限公司 噻唑生产线及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
BE804144A (en) 1972-09-05 1974-02-28 Smith Kline French Lab H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"-(heterocyclyl-alkyl-(thio oxa amino or methylene-alkyl)-guanidines
US4083988A (en) * 1972-09-05 1978-04-11 Smith Kline & French Laboratories Limited Pharmacologically active compounds
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
IT7950977A0 (it) 1979-12-04
FR2444674B1 (fr) 1986-03-28
AU5371679A (en) 1980-06-26
SE7910392L (sv) 1980-06-19
BE880662A (fr) 1980-06-17
IL58960A (en) 1983-06-15
AT375354B (de) 1984-07-25
ZA796814B (en) 1980-11-26
GR73586B (el) 1984-03-26
ES8101569A1 (es) 1980-12-16
GB2038822A (en) 1980-07-30
ES493718A0 (es) 1981-09-01
IT1164076B (it) 1987-04-08
HU182461B (en) 1984-01-30
JPS639512B2 (el) 1988-02-29
FR2444674A1 (fr) 1980-07-18
LU82000A1 (de) 1980-07-21
KR840001074B1 (ko) 1984-07-31
IE49320B1 (en) 1985-09-18
KR840001075B1 (ko) 1984-07-31
KR840004685A (ko) 1984-10-22
KR840004686A (ko) 1984-10-22
KR830001920B1 (ko) 1983-09-23
FI793904A (fi) 1980-06-19
CA1133909A (en) 1982-10-19
YU259382A (en) 1983-02-28
SE444680B (sv) 1986-04-28
DE2950838A1 (de) 1980-07-03
US4200578A (en) 1980-04-29
IE792436L (en) 1980-06-18
ATA793779A (de) 1983-12-15
IL58960A0 (en) 1980-03-31
DK533979A (da) 1980-06-19
YU292179A (en) 1983-02-28
AU533014B2 (en) 1983-10-27
YU259482A (en) 1983-02-28
KR830001263A (ko) 1983-04-29
GB2038822B (en) 1983-01-19
CH642956A5 (fr) 1984-05-15
ES8106715A1 (es) 1981-09-01
JPS5583768A (en) 1980-06-24
ES487035A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
KR850001795B1 (ko) 2,4-이치환된 티아졸 유도체의 제조방법
NL7909054A (nl) Nieuwe verbindingen met formule 1, werkwijze voor de bereiding daarvan; farmaceutische preparaten.
KR880000968B1 (ko) 1, 2-디아미노 시클로부텐-3, 4-디온 및 그의 제조방법
SU1400508A3 (ru) Способ получени производных арилтиазолов
HU176807B (en) Process for preparing guanidino-thiazole and imidazole derivatives
NO170883B (no) Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
JPH06506003A (ja) 新規なイミダゾール誘導体、その製造及びその治療への応用
PL118387B1 (en) Process for preparing novel derivatives of thiadiazole
HU184259B (en) Process for producing 2-imidazoline derivatives
CS199255B2 (en) Method of preparing pharmacologically active compounds
PT77855B (en) Pyridine derivatives
CH615916A5 (el)
HU181960B (en) Process for producing substituted imidazolylmethylthio-compounds
CA1140925A (en) Antisecretory branched chain heterocyclic derivatives, processes for their manufacture and pharmaceutical compositions containing them
DE2604056A1 (de) Thiocarbaminsaeure-derivate
HU181408B (en) Process for preparing substituted furan derivatives
JPH05262761A (ja) アリールアルキルアミン誘導体
NO781572L (no) Fremgangsmaate for fremstilling av bisamidiner
US4157340A (en) N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives
HU182645B (en) Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine
HU176328B (en) Process for preparing isothiocarbamide derivatives
DE3044566A1 (de) N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
EP0452076B1 (en) Thiazole and imidazole derivatives and antiulcer composition containing same
IE54313B1 (en) Pyrimidine anti-ulcer drugs
HU188742B (en) Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed